Effect of Pharmaceutical Potential Endocrine Disruptor Compounds on Protein Disulfide Isomerase Reductase Activity Using Di-Eosin-Oxidized-Glutathion

Danièle Klett, Claire Cahoreau, Mélanie Villeret et al. · 2010

Read Effect of Pharmaceutical Potential Endocrine Disruptor Compounds on Protein Disulfide Isomerase Reductase Activity Using Di-Eosin-Oxidized-Glutathion by Danièle Klett, Claire Cahoreau, Mélanie Villeret et al. (2010) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0009507.txt.

Description

Daniele Klett and colleagues tested hormone like chemicals on a cell enzyme in PLOS ONE in 2010. The enzyme, called PDI, helps new proteins fold in the cell's inner workshop. It also binds hormones such as estrogen and thyroid hormone. Some man made compounds can mimic hormones and disrupt the body. The team asked whether such compounds also impair PDI.

Using a lab assay for one of PDI's tasks, they measured how the compounds changed its activity. Several of them did alter the enzyme's work. That finding flags a new route by which hormone mimics could harm cells. The harm would come not just from false signals, but from faulty protein folding.

Catalog record

CREATORDanièle Klett, Claire Cahoreau, Mélanie Villeret et al.
YEAR2010
COLLECTIONPAPERS
FORMATTXT
FILE SIZE20 KB
LICENSECreative Commons Attribution License
RIGHTSCC BY
SOURCEPLOS ONE

Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0009507

Browse the full library · About the Tower of Babel